Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation

被引:33
作者
Broglie, Martina A. [1 ]
Soltermann, Alex [2 ]
Rohrbach, David [2 ]
Haile, Sarah R. [3 ]
Pawlita, Michael [4 ]
Studer, Gabriela [5 ]
Huber, Gerard F. [6 ]
Moch, Holger [2 ]
Stoeckli, Sandro J. [1 ]
机构
[1] Kantonsspital St Gallen, Dept Otorhinolaryngol Head & Neck Surg, CH-9007 St Gallen, Switzerland
[2] Univ Zurich Hosp, Inst Surg Pathol, Zurich, Switzerland
[3] Kantonsspital St Gallen, Clin Trials Unit, CH-9007 St Gallen, Switzerland
[4] German Canc Res Ctr, Res Program Infect & Canc, Dept Genome Modificat & Carcinogenesis, Heidelberg, Germany
[5] Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[6] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, Zurich, Switzerland
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2013年 / 35卷 / 12期
关键词
oropharyngeal squamous cell carcinoma; outcome; survival; HPV; p16; smoking; alcohol; p53; intensity modulated radiotherapy; risk stratification; GROWTH-FACTOR RECEPTOR; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; RADIATION-THERAPY; TONSILLAR CARCINOMAS; HEAD; RADIOTHERAPY; EXPRESSION; PROGNOSIS; RISK;
D O I
10.1002/hed.23231
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundAnalysis of the impact of risk factors on survival in patients with oropharyngeal squamous cell carcinoma (OPSCC) treated by primary intensity-modulated radiotherapy (IMRT). MethodsOne hundred forty patients were included with tissue microarray (TMA) construction and immunohistochemical analysis in 124 patients (87%). ResultsSurvival analysis of patients classified into 3 risk categories according to an algorithm based on p16, smoking, T classification, and N classification revealed significant differences with a low, intermediate, and high-risk group. There was a significant impact of p53 expression as surrogate marker for smoking on outcome. In multivariate analysis, p16-positivity was a positive predictor and alcohol as well as N classification was a negative predictor for survival. The algorithm was modified based on alcohol instead of smoking with even more significant differences between the groups. ConclusionsA risk model based on multiple factors instead of p16 as single marker can define different risk groups to select patients for treatment deintensification in future prospective clinical trials. (c) 2013 Wiley Periodicals, Inc. Head Neck 35: 1698-1706, 2013
引用
收藏
页码:1698 / 1706
页数:9
相关论文
共 43 条
[1]   Expression of transforming growth factor-α, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy [J].
Aebersold, DM ;
Froehlich, SC ;
Jonczy, M ;
Beer, KT ;
Laissue, J ;
Greiner, RH ;
Djonov, V .
RADIOTHERAPY AND ONCOLOGY, 2002, 63 (03) :275-283
[2]   Human Papillomavirus and Oropharynx Cancer: Biology, Detection and Clinical Implications [J].
Allen, Clint T. ;
Lewis, James S., Jr. ;
El-Mofty, Samir K. ;
Haughey, Bruce H. ;
Nussenbaum, Brian .
LARYNGOSCOPE, 2010, 120 (09) :1756-1772
[3]  
Andl T, 1998, CANCER RES, V58, P5
[4]   Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer [J].
Ang, K. Kian ;
Harris, Jonathan ;
Wheeler, Richard ;
Weber, Randal ;
Rosenthal, David I. ;
Nguyen-Tan, Phuc Felix ;
Westra, William H. ;
Chung, Christine H. ;
Jordan, Richard C. ;
Lu, Charles ;
Kim, Harold ;
Axelrod, Rita ;
Silverman, C. Craig ;
Redmond, Kevin P. ;
Gillison, Maura L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) :24-35
[5]  
Begum S, 2003, CLIN CANCER RES, V9, P6469
[6]   Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer [J].
Bernier, J ;
Domenge, C ;
Ozsahin, M ;
Matuszewska, K ;
Lefèbvre, JL ;
Greiner, RH ;
Giralt, J ;
Maingon, P ;
Rolland, F ;
Bolla, M ;
Cognetti, F ;
Bourhis, J ;
Kirkpatrick, A ;
van Glabbeke, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1945-1952
[7]  
BLOT WJ, 1988, CANCER RES, V48, P3282
[8]   Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus [J].
Braakhuis, BJM ;
Snijders, PJF ;
Keune, WJH ;
Meijer, CJLM ;
Ruijter-Schippers, HJ ;
Leemans, CR ;
Brakenhoff, RH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (13) :998-1006
[9]   Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma [J].
Daly, Megan E. ;
Lieskovsky, YeeYie ;
Pawlicki, Todd ;
Yau, Jervis ;
Pinto, Harlan ;
Kaplan, Michael ;
Fee, Willard E. ;
Koong, Albert ;
Goffinet, Don R. ;
Xing, Lei ;
Le, Quynh-Thu .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (03) :211-220
[10]   Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial [J].
Fakhry, Carole ;
Westra, William H. ;
Cmelak, Sigui Li Anthony ;
Ridge, John A. ;
Pinto, Harlan ;
Forastiere, Arlene ;
Gillison, Maura L. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (04) :261-269